Spironolactone in patients with heart failure [1] (multiple letters)

New England Journal of Medicine

Volumn 342, Issue 2, 2000, Pages 132-134

  Fernandez, H M ^a   Leivzig, R M ^a   Larkin, R J ^a   Atlas, S A ^a   Donohue, T J ^a   Vanpee, D ^a   Swine, C ^a   Glick, G ^a   Pitt, B ^a   Perez, A ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE RECEPTOR; CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; PLACEBO; SPIRONOLACTONE; DIURETIC AGENT;

AGED; DOSE CALCULATION; DRUG EFFECT; DRUG USE; HEART FAILURE; HUMAN; LETTER; PATIENT MONITORING; PRIORITY JOURNAL; CONGESTIVE HEART FAILURE; DRUG COMBINATION; NOTE; CHEMICALLY INDUCED DISORDER; HYPERKALEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIGOXIN; DIURETICS; DRUG THERAPY, COMBINATION; FUROSEMIDE; HEART FAILURE, CONGESTIVE; HUMANS; SPIRONOLACTONE; DIABETES MELLITUS, TYPE 2; HYPERKALEMIA;

EID: 0034642395     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200001133420213     Document Type: Letter

References (0)